Avalon GloboCare Announces Execution Of Purchase Agreement For Acquisition Of SenlangBio In All Stock Transaction; Will Sell 15.6% Equity Interest In SenlangBio To Institutional Healthcare Investor For $30M
Avalon GloboCare Corp. (NASDAQ:AVCO) ("Avalon" or "the Company"), a clinical-stage global developer of cell-based technologies and therapeutics, today announced that it has entered into a